For the Inventor, By the Inventor

Enter assignee name

Seoul, South Korea

Je Il Pharmaceutical Co., Ltd.

USPTO Granted Patents = 9

EPO Patents = 6

Trademarks = 1

Forward Citations = 60

Loading Chart...

Loading Chart...

44 inventors (with patents filed for the assignee):

Myung-Hwa Kim (5 out of 5 patents)

In-Hae Ye (4 out of 4 patents)

Jong-Hee Choi (4 out of 4 patents)

4. Chun-Ho Park (3 out of 5 patents)

5. Kwang-Woo Chun (3 out of 3 patents)

6. Hyunho Lee (2 out of 296 patents)

7. Kwangwoo Chun (2 out of 2 patents)

8. Bo-Young Joe (2 out of 2 patents)

9. Dong-wook Kim (1 out of 69 patents)

10. Joseph Kim (1 out of 3 patents)

11. Jeongmin Kim (1 out of 2 patents)

12. Yoonsun Park (1 out of 1 patent)

13. Eunsung Jang (1 out of 1 patent)

14. Hyeongchan Oh (1 out of 1 patent)

15. Jeong-Min Kim (1 out of 1 patent)

9 patents: Sort by Forward Citations

1. 10696671 - Imidazo[1,2-A]pyridine derivatives, methods for preparing the same and use thereof (2020-06-30),

2. 10464919 - Tricyclic derivative compound, method for preparing same, and pharmaceutical composition comprising same (2019-11-05),

3. 9522911 - Crystalline forms of tricyclic compound acid salt or hydrate thereof, and method for making thereof (2016-12-20),

4. 8906395 - Pharmaceutical composition in which solubility of partially soluble tricyclic derivative is improved (2014-12-09),

5. 8815891 - Tricyclic derivative or pharmaceutically acceptable salts thereof, preparation method thereof, and pharmaceutical composition containing the same (2014-08-26),

6. 8742160 - Method for preparing tricyclic derivatives (2014-06-03),

7. 8492149 - Efficient generation of neural progenitors, neurons, and dopaminergic neurons from human embryonic stem cells (2013-07-23),

8. 8334277 - {4-[2-(dimethylamino)-1-(1-hydroxycyclohexyl)ethyl]phenoxy}phosphate or a pharmaceutically acceptable salt thereof, a production method therefor and a pharmaceutical composition for preventing and treating central nervous system disorders containing the same as an active component (2012-12-18),

9. 5859016 - Memory enhancing and anti-dementia agent containing dehydroevodiamine (1999-01-12),

Je Il Pharmaceutical Co., Ltd. is a leading pharmaceutical company specializing in the development, manufacturing, and marketing of high-quality pharmaceutical products. With a strong focus on research and innovation, Je Il Pharmaceutical is committed to providing safe and effective medications to improve the health and well-being of patients worldwide. Visit our website to learn more about our products and services.

This text is generated by artificial intelligence and may not be accurate.

Company Badge

USPTO Data Jan 1 1976 - Dec 30 2025

9 Patents

#375 in Seoul

#1,130 in South Korea

Seoul, South Korea

Je Il Pharmaceutical Co., Ltd.

Forward Citations = 60

44 inventors:

Myung-Hwa Kim (5 out of 5 patents)

In-Hae Ye (4 out of 4 patents)

Jong-Hee Choi (4 out of 4 patents)

4. Chun-Ho Park (3 out of 5 patents)

5. Kwang-Woo Chun (3 out of 3 patents)

Please report any incorrect information to support@idiyas.com

Loading…